1. Academic Validation
  2. Vitreous Inflammation as an Early Indicator of Retinal Ganglion Cell Loss Following Acute Optic Nerve Injury in Mice

Vitreous Inflammation as an Early Indicator of Retinal Ganglion Cell Loss Following Acute Optic Nerve Injury in Mice

  • bioRxiv. 2025 Dec 23:2025.12.20.694725. doi: 10.64898/2025.12.20.694725.
Shichu Chang 1 Weijia Fan 2 Jiahui Wu 1 Lei Xu 3 Virginia Lee 1 Charlotte Zhang 1 Edward P Kronenberg 1 Wenjin Xu 1 Hu Yang 3 Hao F Zhang 2 Xiaorong Liu 1 4 5
Affiliations

Affiliations

  • 1 Department of Biology, University of Virginia, Charlottesville, VA.
  • 2 Department of Biomedical Engineering, Northwestern University, Evanston, IL.
  • 3 Linda and Bipin Doshi Department of Chemical and Biochemical Engineering, Missouri University of Science and Technology, Rolla, MO.
  • 4 Department of Psychology, University of Virginia, Charlottesville, VA.
  • 5 Program in Fundamental Neuroscience, University of Virginia, Charlottesville, VA.
Abstract

Retinal ganglion cell (RGC) degeneration in optic neuropathies is often preceded by neuroinflammatory changes, yet the earliest in vivo indicators of this process remain poorly defined. Here, we identified vitreous hyperreflective foci (VHRFs) by visible-light optical coherence tomography (vis-OCT) as an early inflammatory signature of RGC injury. Longitudinal vis-OCT imaging after optic nerve crush (ONC) revealed that VHRFs emerged as early as 6 hours post-injury and peaked before the significant RGC loss. Confocal analysis showed that these VHRFs corresponded to activated amoeboid microglia undergoing vertical migration from the outer to inner retina and horizontal movement toward the optic nerve head area. Similar amoeboid microglia were also observed in the anterior segment, suggesting a global ocular inflammatory response to the ONC injury. RNAscope in situ hybridization further demonstrated elevated IL-1β expression in vitreous amoeboid microglia. Moreover, pharmacological blockade of IL-1 signaling with an IL-1 receptor antagonist significantly reduced VHRFs, suppressed microglial migration, and delayed RGC loss. Taken together, our findings identify VHRFs as a previously unrecognized early danger signal for RGC degeneration and highlight IL-1-mediated inflammation as a tractable early therapeutic target for preventing RGC degeneration and vision loss.

Figures
Products